FDA Approved: ELAPRASE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

FDA approved a supplemental application for ELAPRASE (idursulfase) from Takeda Pharmaceuticals America, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hunter Syndrome
• Mucopolysaccharidosis Type Ii

Drugs mentioned

• Elaprase (idursulfase)

Snippet

SUPPL AP for ELAPRASE (IDURSULFASE)